Our Scientists Team
Kent Miller, Ph.D., M.D.
Dr. Miller is Professor Emeritus of Medicine and Microbiology at the University Of Miami School Of Medicine where he served as Chief of Laboratory Medicine and Director of clinical laboratories for the University of Miami Hospitals and Clinics. Previously, Dr. Miller served as the Assistant Director and Chief of Laboratory Medicine for the New York State Department of Health, and Associate Professor of Pathology at Albany Medical College.
Dr. Miller's research interests are primarily focused on clinical diagnostics and the clinical applications of natural toxins. He performed extensive work on bacterial toxins, especially tetanus toxin, and the development of tetanus toxoid for human use. While at the University of Miami, Dr. Miller collaborated with Dr. Maury Sanders to research the antiviral properties of snake a-toxins. Dr. Miller continued research on PVX (formerly known as PANAVIRA™) and to develop innovative clinical diagnostics. Furthermore, Dr. Miller has authored several papers in peer reviewed journals on this antiviral technology. He has one approved patent and another patent application in review for PVX.
Dr. Miller oversees the management and monitoring of current research processes, the development of the new bioengineered production process, support of the FDA approval process and support of all new patent applications.
Jay E. Yourist, Ph.D.
As a colleague in the Department of Microbiology at the University of Miami, Dr. Yourist worked with Dr. Miller, his Ph.D. advisor, to perform the initial basic research of this technology including its mechanism of action.
As the founder and CEO of CRP Network, LLC in Miami, Florida, he guided an organization that provided clinical research services for new biotechnologies, nutraceuticals and medical devices primarily in the specialty areas of cardiovascular disease, diabetes, infectious disease, rheumatology, wound care, and physical rehabilitation.
Also, Dr. Yourist served as an Assistant Professor of Medicine at the University Of Miami School Of Medicine, where he had both teaching and basic research responsibilities. His research included studies in virology, neurochemistry and enzymology focusing on processes mediated by phosphorylation.
Dr. Yourist has published several papers and has a patent application in current review regarding "Coordinated Healthcare and Disability Management Systems."
Dr. Yourist will serve as our Chief Executive Officer (See Our Management Team) and in addition to his overall management responsibilities he will concentrate on the clinical trials, the FDA approval process, and the development of the new synthesis and bioengineered production processes.
Patrick Corsino, Ph.D.
Dr. Patrick Corsino received his Bachelor of Science degree in Medical Biochemistry from the University of Birmingham in the United Kingdom. He then earned his PhD in Pharmacology and Therapeutics from the University of Florida under the guidance of Dr. Brian Law. After graduation he remained at the University for an additional 2 years as a post-doctoral associate with a fellowship grant from the National Institutes of Health. His research during this period was focused primarily on kinases involved in cell cycle regulation, specifically in regards to cancer.
Dr. Corsino then moved to South Florida to work as quality control director and laboratory manager at one of the largest compounding pharmacies in the United States. During this time he oversaw production of a wide variety of pharmaceuticals and their appropriate testing. Dr. Corsino now works as the R&D Manager at Nuovo Biologics, directing research to elucidate the mechanism of action of the drugs in the current pipeline.
Dr. Corsino has presented his research at meetings and conferences across the country and has been an author on 13 publications. He holds a US patent for a portion of his research, and is an owner or a co-owner in 3 different companies.
Lester Mandelker, D.V.M.
Dr. Mandelker, who has been in private practice since 1972 is a graduate of Michigan State University for both his undergraduate and veterinary degrees. The Community Veterinary Hospital, in Largo Florida, is an AAHA Certified Hospital and Dr. Mandelker maintains active memberships in AVMA, FVMA, AAHA, FVMA, ABVP and the FAAVPT.
Over the last several decades Dr. Mandelker has maintained a high degree of peer respect and acknowledgement. From 1990 to 1992, he was the President/Secretary of the Pinellas County (Florida) Veterinary Medical Association. He was selected among the nation's top veterinarians 2006 & 2007 by the Consumer's Research Council of America and is a Member of the Executive Board of the Association for Pet Obesity Prevention. He was Chairman of Examination Committee of the American Board of Veterinary Practitioners from 1900 to 1992.
Since 1986, Dr. Mandelker has been a Diplomat of The American Board of Veterinary Practitioners and is certified in Canine and Feline Medicine. His Specialty Interest is Pharmacology, Nutraceuticals and Antioxidants. Dr. Mandelker is also a Fellow of the American Academy of Pharmacology and Therapeutics (FAAVPT).
Dr. Mandelker has published over 175 scientific articles on pharmacology, medicine and nutraceuticals in journals such as: AVMA journal, VM/SAC, Veterinary Forum and The Veterinary Clinics of North America.
Dr. Mandelker and done extensive work in pharmacology and first introduced various human pharmacological agents to the veterinary medicine such as Tramadol analgesic for pain in dogs and cats, Niacin for hyperlipidemia in dogs, Amitryptyline for use in boarding dogs and Accolate for use in feline sinusitis and canine respiratory diseases as well as many other first. He continues his active interest in animal pharmacology as a Pharmacology Consultant for Veterinary Forum, the Veterinary Information Network and is in demand as a speaker on Veterinary Pharmacology.